子宫内膜癌患者新辅助化疗的预后影响因素分析

Analysis of influence factors of prognosis in patients with endometrial carcinoma receiving neoadjuvant chemotherapy

目的 分析化疗前血红蛋白及血小板水平对子宫内膜癌新辅助化疗后手术治疗疗效及预后的影响.方法 对新辅助化疗后行手术治疗的104例子宫内膜癌患者临床资料进行回顾性分析,分析影响子宫内膜癌患者新辅助化疗疗效的因素.单因素分析采用Х^2检验,多因素分析采用logistic回归法.结果 多因素Logistic回归分析FIGO分期（OR=3.234,95％ CI：1.324～ 13.454）和淋巴结转移（OR=8.235,95％CI：1.563～18.574）是影响子宫内膜癌新辅助化疗疗效的独立因素;多因素Cox回归模型分析显示：FIGO分期（HR=4.342,95％CI：1.643～ 15.856）和淋巴结转移（HR=3.853,95％ CI：1.864～9.675）是影响子宫内膜癌新辅助化疗5年生存率的独立因素.结论 对于接受新辅助化疗后手术治疗的子宫内膜癌患者的疗效及预后,与化疗前血红蛋白及血小板水平无明显相关性,与淋巴结转移、FIGO分期有关.

Objective To investigate the influence of pre-chemotherapy hemoglobin and platelet levels on the effect of chemotherapy and prognostic outcome in patients with endometrial carcinoma （EC）.Methods 104 patients with EC who underwent surgical treatment following neoadjuvant chemotherapy were retrospectively analyzed.Multiple logistic regression was carried out to evaluate the relationship between the probability of achieving an optimal clinical response and the variables.The log-rank test was used to compare the homogeneity of progression-free survival and overall survival functions across strata defined by categories of prognostic variables.Results The Cox proportional hazard model was used to assess the significance of potential prognostic factors for progression-free survival and overall survival.Multivariate logistic regression analysis indicated that FIGO staging （OR =3.234,95 ％ CI：1.324-13.454） and lymph node metastasis （OR =8.235,95 ％ CI：1.563-18.574） were independent factors of influencing effects of new adjuvant chemotherapy in the treatment of EC patients.Multivariate Cox regression model analysis showed that the FIGO staging（HR =4.342,95％ CI：1.643-15.856） and lymph node metastasis （HR =3.853,95％ CI：1.864-9.675） were independent factors of influencing 5 years survival rate of EC patients received new adjuvant chemotherapy.Conclusion The curative effect and prognosis after receiving neoadjuvant chemotherapy operation in treatment of EC patients before chemotherapy,there was no significant correlation between hemoglobin and platelet levels,and lymph node metastasis,FIGO stage.